Status:
UNKNOWN
General Tissue Response Classification System After Chemotherapy
Lead Sponsor:
West China Hospital
Conditions:
Stomach Adenocarcinoma
Eligibility:
All Genders
18-75 years
Brief Summary
This research intend to collect the information of gastric cancer patients who received preoperative neoadjuvant chemotherapy and radical gastric ectomy at Department of Gastrointestinal Surgery, West...
Detailed Description
Gastric cancer is ranked the third malignancy carcinoma which related deaths. In china, gastric cancer always ranked in the top three cancer-related deaths. Early diagnosis ratio of gastric caner is l...
Eligibility Criteria
Inclusion
- The diagnosis of gastric cancer was clear，Patients with definitely clinical evidence of locally advanced disease (cT3 ⁄ 4、N-/+、M0).
- Preoperative chemotherapy has been administered，and intended to receive surgical resection.
- Age:less than or equal to 75 years old and more than 18 years old;
- Without any other malignant tumor, without any serious concomitant disease.
- Eastern Cooperative Oncology Group (ECOG) physical status score \<2, America Society of Anesthesiologist (ASA) score\<3
- No restriction on gender or race; Informed consent has been signed by patient or entrusted agent；
Exclusion
- Previous history of gastric ulcer or gastric perforation;
- Previous operation history at upper abdominal, except laparoscopic cholecystectomy;
- Emergency operation caused by obstruction, perforation,and acute hemorrhage;
- The patient can not tolerate the surgical treatment which caused by other serious concomitant disease, such as severe pulmonary disease, cardiac clinical function below are below level 2, pulmonary infection, moderate or severe chronic obstructive pulmonary disease (COPD), chronic bronchitis
- Patient has severe mental illness
- The patient and agent request to withdraw from the clinical study after signing the consent form.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03791268
Start Date
January 1 2019
End Date
December 31 2020
Last Update
January 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital, Sichuan University
Chengdu, Sichuan, China, 610041